Early Detection of Prostate Cancer in 2020 and Beyond: Facts and Recommendations for the European Union and the European Commission.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33384200.
- Also identified by DOI 10.1016/j.eururo.2020.12.010.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The burden of prostate cancer is increasing. Therefore, we need to implement a contemporary, organized, risk-stratified program for early detection to reduce both the harm from the disease and potential overdiagnosis and overtreatment, while avoiding underdiagnosis to considerably improve the harm-to-benefit ratio.
Medical subject headings
- Overtreatment
- Prostatic Neoplasms